Pegvaliase for the treatment of phenylketonuria: Final results of a long-term phase 3 clinical trial program
2024 · Molecular Genetics and Metabolism Reports · 14 citations
https://doi.org/10.1016/j.ymgmr.2024.101084
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1
Papers
0
Citations
0
h-index
0
i10-index
Cary O. Harding is an academic researcher. The author has contributed to research in topics: Ubiquitin and proteasome pathways & Peptidase Inhibition and Analysis & Protein Degradation and Inhibitors.
Click to start Chat